Japan Lifeline Co Ltd
TSE:7575

Watchlist Manager
Japan Lifeline Co Ltd Logo
Japan Lifeline Co Ltd
TSE:7575
Watchlist
Price: 1 379 JPY -1.01% Market Closed
Market Cap: 96.7B JPY
Have any thoughts about
Japan Lifeline Co Ltd?
Write Note

Japan Lifeline Co Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Japan Lifeline Co Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Japan Lifeline Co Ltd
TSE:7575
Net Issuance of Common Stock
-ÂĄ6.5B
CAGR 3-Years
N/A
CAGR 5-Years
-76%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Net Issuance of Common Stock
-ÂĄ13.4B
CAGR 3-Years
-1 395%
CAGR 5-Years
-353%
CAGR 10-Years
-97%
Olympus Corp
TSE:7733
Net Issuance of Common Stock
-ÂĄ165B
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
-145%
Sysmex Corp
TSE:6869
Net Issuance of Common Stock
-ÂĄ11.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nihon Kohden Corp
TSE:6849
Net Issuance of Common Stock
-ÂĄ3.4B
CAGR 3-Years
-32%
CAGR 5-Years
-409%
CAGR 10-Years
N/A
JEOL Ltd
TSE:6951
Net Issuance of Common Stock
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Japan Lifeline Co Ltd
Glance View

Market Cap
96.7B JPY
Industry
Health Care

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. The company is headquartered in Shinagawa-Ku, Tokyo-To and currently employs 1,167 full-time employees. The firm is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

Intrinsic Value
2 008.65 JPY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Japan Lifeline Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
-6.5B JPY

Based on the financial report for Sep 30, 2024, Japan Lifeline Co Ltd's Net Issuance of Common Stock amounts to -6.5B JPY.

What is Japan Lifeline Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-76%

Over the last year, the Net Issuance of Common Stock growth was -226%.

Back to Top